Silverleafe Capital Partners, LLC Gt Biopharma, Inc. Transaction History

Silverleafe Capital Partners, LLC

  • $279 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 04, 2022
SELL
$3.05 - $7.08 $320,250 - $743,400
-105,000 Closed
0 $0
Q3 2021

Oct 13, 2021
BUY
$6.68 - $15.26 $6,680 - $15,260
1,000 Added 0.96%
105,000 $708,000
Q2 2021

Jul 06, 2021
BUY
$7.19 - $18.96 $747,760 - $1.97 Million
104,000 New
104,000 $1.61 Million

Others Institutions Holding GTBP

# of Institutions
4
Shares Held
564
Call Options Held
0
Put Options Held
0
View Full List

About GT Biopharma, Inc.

GTBP Quotes by TradingView
  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $81.7M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Silverleafe Capital Partners, LLC Portfolio

Follow Silverleafe Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverleafe Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverleafe Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email